|XTL BIOPHARM SP ADR||(NQ: XTLB)|
3.410 USD UNCHANGED
Streaming Delayed Price / Updated: 8:10 PM EDT, Apr 22, 2014 / Add to My Watchlist
Price and VolumeDetailed Quote
Featured NewsMore News
Featured NewsRead More
XTL Biopharmaceuticals In-licenses hCDR1, a Phase 2 Clinical Stage Asset for the Treatment of Lupus
January 08, 2014
Following the Acquisition of the Controlling Stake by XTL, Proteologics Appoints Board Members and Chairman
December 05, 2012
XTL Biopharmaceuticals Acquires Stake in Proteologics Ltd.
November 26, 2012
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here